Literature DB >> 15474475

Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j.

Joan Sayós1, Agueda Martínez-Barriocanal, Friederike Kitzig, Teresa Bellón, Miguel López-Botet.   

Abstract

The CD85j inhibitory receptor (also termed ILT2 or LIR-1) is a type-I transmembrane protein that belongs to the Ig superfamily and is expressed by different leukocyte lineages. The extracellular region of CD85j binds HLA class I molecules and its cytoplasmic domain displays four immunoreceptor tyrosine-based inhibition motifs (ITIM). Upon tyrosine phosphorylation CD85j recruits the SHP-1 tyrosine phosphatase, involved in negative signaling. In order to identify other molecules to which CD85j might interact with in a phosphotyrosine-dependent manner, a cDNA B-cell library was screened in a three-hybrid system in yeast using the CD85j cytoplasmic tail as bait in the presence of the Src-kinase c-fyn420, 531Y-F, 176R-Q mutant. In this system, the C-terminal Src kinase (Csk) was shown to interact with CD85j. Phosphorylation-dependent recruitment of Csk to the CD85j cytoplasmic tail was confirmed in CD85j-transfected mammalian cells by immunoprecipitation and Western blot analysis. Mutational analyses and phospho-peptide mapping suggested that the SH2 domain of Csk may preferentially bind to ITIM Y562 of CD85j; yet, mutation to phenylalanine of Y533, Y614, and Y644 also significantly reduced Csk recruitment by CD85j. Even though CD85j was detected in both anti-SHP1 and CSK immunoprecipitates, these two molecules did not co-precipitate together with CD85j. Our data support the possibility that Csk regulates the function of CD85j.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474475     DOI: 10.1016/j.bbrc.2004.09.097

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  CD84 negatively regulates IgE high-affinity receptor signaling in human mast cells.

Authors:  Damiana Álvarez-Errico; Irene Oliver-Vila; Erola Ainsua-Enrich; Alasdair M Gilfillan; César Picado; Joan Sayós; Margarita Martín
Journal:  J Immunol       Date:  2011-11-07       Impact factor: 5.422

Review 2.  PD-1 signaling in primary T cells.

Authors:  James L Riley
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

3.  Crystal structure of leukocyte Ig-like receptor LILRB4 (ILT3/LIR-5/CD85k): a myeloid inhibitory receptor involved in immune tolerance.

Authors:  Hao Cheng; Fiyaz Mohammed; Gol Nam; Yong Chen; Jianxun Qi; Lee I Garner; Rachel L Allen; Jinghua Yan; Benjamin E Willcox; George F Gao
Journal:  J Biol Chem       Date:  2011-03-30       Impact factor: 5.157

Review 4.  New Targets for Antiviral Therapy: Inhibitory Receptors and Immune Checkpoints on Myeloid Cells.

Authors:  Yanni Liu; Paul Nicklin; Yuan He
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

5.  Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts.

Authors:  Wei Zhang; Siyuan Liang; Juan Wu; Anatolij Horuzsko
Journal:  Transplantation       Date:  2008-10-27       Impact factor: 4.939

6.  Analysis of immunoglobulin-like transcripts (ILTs) in lymphocytes with sHLA-G and IL10 from SLE patients.

Authors:  Jiaxi Chen; Bo Shen; Yufei Jiang; Li Jun; Ming Zhu; Baoguo Chen; Chibo Liu
Journal:  Clin Exp Med       Date:  2012-05-06       Impact factor: 3.984

Review 7.  Negative signaling by inhibitory receptors: the NK cell paradigm.

Authors:  Eric O Long
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

8.  Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6--STAT3 signaling pathway.

Authors:  Siyuan Liang; Vladimir Ristich; Hisashi Arase; Jean Dausset; Edgardo D Carosella; Anatolij Horuzsko
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-11       Impact factor: 11.205

9.  Human papillomavirus immunization is associated with increased expression of different innate immune regulatory receptors.

Authors:  V Colmenares; D E Noyola; A Monsiváis-Urenda; M Salgado-Bustamante; L Estrada-Capetillo; R González-Amaro; L Baranda
Journal:  Clin Vaccine Immunol       Date:  2012-05-09

Review 10.  Biochemical and Functional Insights into the Integrated Regulation of Innate Immune Cell Responses by Teleost Leukocyte Immune-Type Receptors.

Authors:  Chenjie Fei; Joshua G Pemberton; Dustin M E Lillico; Myron A Zwozdesky; James L Stafford
Journal:  Biology (Basel)       Date:  2016-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.